Stem cell therapy for cornea injuries represents a groundbreaking advancement in ophthalmologic treatment, offering new hope for patients previously considered untreatable.This innovative approach utilizes cultivated autologous limbal epithelial cells (CALEC) obtained from a healthy eye to regenerate and restore the corneal surface.